| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/22/2006 | US20060133999 Method for the diagnosis of Helicobacter pylori infection, and a diagnostic kit for performing the method |
| 06/22/2006 | US20060133964 Closed loop automated matrix removal |
| 06/22/2006 | US20060133962 Contact combustion gas sensor |
| 06/22/2006 | US20060133961 Bi-material cantilevers with flipped over material sections and structures formed therefrom |
| 06/22/2006 | US20060133959 Luminometer for simultaneously detecting multiple samples |
| 06/22/2006 | US20060133958 Multi-step analysis and detection, separation, plasma from whole blood |
| 06/22/2006 | US20060133953 apparatus comprising functionalized piezoelectric resonator for use in monitoring glucose, potassium, calcium and/or carbon dioxide concentrations in blood samples |
| 06/22/2006 | US20060133952 Biosensor utilizing a resonator having a functionalized surface |
| 06/22/2006 | US20060131542 Particles |
| 06/22/2006 | US20060131237 filtering a liquid sample contained in multiwell plates; removal of filtrate droplets from the underside of a membrane; each droplet is directed from said membrane by an absorbent for said liquid; wicking structure in a manifold, which channels droplets of liquid away from membrane |
| 06/22/2006 | US20060131186 Hydrogen sensor, apparatus for measuring hydrogen concentration, and method for measuring hydrogen concentration |
| 06/22/2006 | US20060131171 Analysis implement with opening in insulation film |
| 06/22/2006 | US20060130565 Measurement of total reactive isocyanate groups in samples using bifunctional nucleophiles such as 1,8-diaminonaphthalene (dan) |
| 06/22/2006 | DE202005020150U1 Reference material for quality control of antibody index measurements, useful in diagnostic determination of immunoglobulin levels against neurotropic pathogens, comprises serum and liquor cerebrospinalis pairs |
| 06/22/2006 | DE102005007872B3 Temperature measurement in microfluidic channel of microfluidic device, comprises irradiating volume element of the channel by pulsed laser, elastic scattering and detecting Raman light and converting the Raman light to signals |
| 06/22/2006 | DE102004060322A1 Analysesystem mit einem elektrischen Anschlusssystem für ein Testelement Analysis system with an electrical connection system for a test element |
| 06/22/2006 | DE102004059169A1 Verfahren zum Testen von Substanzen an Biomatrices Method for testing substances on biomatrices |
| 06/22/2006 | CA2761260A1 Transmission spectroscopy system for use in the determination of analytes in body fluid |
| 06/22/2006 | CA2592350A1 Functional assays for cholesterol absorption inhibitors |
| 06/22/2006 | CA2592339A1 Test sensor dispensing devices and test sensor ejection mechanisms |
| 06/22/2006 | CA2591918A1 Cancer-specific spanx-n markers |
| 06/22/2006 | CA2591776A1 Assay |
| 06/22/2006 | CA2590982A1 Method for diagnosing hepatic diseases |
| 06/22/2006 | CA2590925A1 Automated immunoassay cassette, apparatus and method |
| 06/22/2006 | CA2590751A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 06/22/2006 | CA2590521A1 Marker for readings taken from alternative site tests |
| 06/22/2006 | CA2590394A1 Single nucleotide polymorphism (snp) associated to type ii diabetes |
| 06/22/2006 | CA2590363A1 A method of differentiating between blood and control solutions containing a common analyte |
| 06/22/2006 | CA2590322A1 Method for identifying modulators of the activity of ion-channels receptors |
| 06/22/2006 | CA2590319A1 Analyte test device having a trend-indicating display |
| 06/22/2006 | CA2590010A1 Transgenic animals for assessing drug metabolism and toxicity |
| 06/22/2006 | CA2589976A1 Rapid microbial detection and antimicrobial susceptibility testing |
| 06/22/2006 | CA2589751A1 Prion sensors for diagnosis of transmissible spongiform encephalopathy or for detection of prions, and use thereof |
| 06/22/2006 | CA2589135A1 Cd99 as target/marker for insulin resistance |
| 06/22/2006 | CA2589037A1 Single nucleotide polymorphism (snp) associated to type ii diabetes |
| 06/22/2006 | CA2587589A1 Engineered antibodies and immunoconjugates |
| 06/22/2006 | CA2587136A1 Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens |
| 06/21/2006 | EP1672369A1 Method of determination of blood coagulation parameters, especially in flow through systems |
| 06/21/2006 | EP1672368A1 Diagnostic and therapeutic epitope and transgenic plant |
| 06/21/2006 | EP1672367A1 Method for screening autoantigen |
| 06/21/2006 | EP1672366A2 Methods and compositions for opsonophagocytic assays |
| 06/21/2006 | EP1672365A1 Means and methods for determining and/or influencing cellular transportation |
| 06/21/2006 | EP1672356A1 Sensor having integrated light detector and/or light source |
| 06/21/2006 | EP1672083A1 Diagnostic kit |
| 06/21/2006 | EP1672082A2 A method for detecting a target substance using a nucleic acid probe |
| 06/21/2006 | EP1672072A2 Cloning and characterisation of the gene flbA of H. pylori; production of flagella-free strains |
| 06/21/2006 | EP1672070A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/21/2006 | EP1672065A1 Protein expressed in nk cell |
| 06/21/2006 | EP1671698A2 Device for holding a substance library carrier |
| 06/21/2006 | EP1671689A1 Method for monitoring the quality of a herbal medicine |
| 06/21/2006 | EP1671648A1 Prevention and treatment for gvhd |
| 06/21/2006 | EP1671645A1 Remedy and detection drug for bile duct cancer |
| 06/21/2006 | EP1671625A1 Nanoparticles |
| 06/21/2006 | EP1671251A2 Method for simulating the interaction of chemical substances and living organisms |
| 06/21/2006 | EP1671236A2 Using multiple perturbations to elucidate connectivity in network systems |
| 06/21/2006 | EP1671134A2 High throughput automated seed analysis system |
| 06/21/2006 | EP1671133A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor1 (adipor1) |
| 06/21/2006 | EP1671132A2 Methods for selecting compounds using antibodies with activity as agonist, antagonist or allosteric modulators |
| 06/21/2006 | EP1671131A1 Methods and kits for detection of prion diseases |
| 06/21/2006 | EP1671130A2 Method for discriminating between ischemic and haemorrhagic stroke |
| 06/21/2006 | EP1671129A1 Compounds and methods for promoting angiogenesis by using a gamma-secretase inhibitor or inhibiting the gamma-secretase pathway |
| 06/21/2006 | EP1671128A2 Multiplex binding and activity assays |
| 06/21/2006 | EP1671127A2 Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep (rnpep) |
| 06/21/2006 | EP1671126A2 Diagnosis and treatment of mycobacterial infections |
| 06/21/2006 | EP1671125A1 Label-free detection of biomolecules |
| 06/21/2006 | EP1671124A1 Film layer for detection of immobilized analytes |
| 06/21/2006 | EP1671123A1 Cells containing a nanopatch sensor in their membrane |
| 06/21/2006 | EP1671122A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2) |
| 06/21/2006 | EP1671121A2 Systems and methods for detecting biological features |
| 06/21/2006 | EP1671120A1 Automatic analysis device and method for monitoring polymer production by means of mass spectrometry |
| 06/21/2006 | EP1671119A1 Method and device for monitoring a thread |
| 06/21/2006 | EP1671118A2 Cyanide sensing compounds and uses thereof |
| 06/21/2006 | EP1671117A2 Sample processing system |
| 06/21/2006 | EP1671115A1 Electrochemical sensor |
| 06/21/2006 | EP1671112A1 Improved isoelectric focusing gels and methods of use thereof |
| 06/21/2006 | EP1671102A1 Integrated apparatus for hematological analyses and related method |
| 06/21/2006 | EP1671094A2 Drug authentication |
| 06/21/2006 | EP1670943A2 Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases |
| 06/21/2006 | EP1670940A1 Method for identification of suitable fragmentation sites in a reporter protein |
| 06/21/2006 | EP1670936A1 Signal amplification using a synthetic zymogen |
| 06/21/2006 | EP1670935A1 Neural colony forming assay |
| 06/21/2006 | EP1670932A2 Libraries of recombinant chimeric proteins |
| 06/21/2006 | EP1670901A2 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
| 06/21/2006 | EP1670900A2 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 06/21/2006 | EP1670895A2 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof |
| 06/21/2006 | EP1670822A2 Igf binding proteins |
| 06/21/2006 | EP1670820A2 Antigens for an east coast fever vaccine |
| 06/21/2006 | EP1670816A2 Fluorescence assay for kinase activity |
| 06/21/2006 | EP1670813A2 Rho antibody and tag to purify cell surface proteins |
| 06/21/2006 | EP1670811A2 Shc proteins as therapeutic targets in proliferative diseases |
| 06/21/2006 | EP1670789A2 Fluorescent probes for use in protein kinase inhibitor binding assay |
| 06/21/2006 | EP1670509A2 Multiplex vaccines |
| 06/21/2006 | EP1670497A1 METHODS FOR IDENTIFYING MODULATORS OF PROTEIN KINASE C-EPSILON (PKCϵ) AND METHOD OF TREATMENT OF ABERRANT GLUCOSE METABOLISM ASSOCIATED THEREWITH |
| 06/21/2006 | EP1670445A2 Methods of preventing or treating recurrence of myocardial infarction |
| 06/21/2006 | EP1670422A2 Identification of kinase inhibitors |
| 06/21/2006 | EP1670415A2 Animal model for protease activity and liver damage |
| 06/21/2006 | EP1670414A2 Use of cxcr4 protein expression on the surface of stem cells as a marker for tumor tropic potential |
| 06/21/2006 | EP1670356A1 Personal diagnostic devices and related methods |
| 06/21/2006 | EP1670350A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 06/21/2006 | EP1670347A2 Fluorescence polarization imaging devices and methods |